Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease

Journal of Clinical Pathology

Volumn 49, Issue 6, 1996, Pages 508-510

  Burgmann, H ^a   Hollenstein, U ^a   Maca, T ^a   Zedwitz Liebenstein, K ^a   Thalhammer, F ^a   Koppensteiner, R ^a   Ehringer, H ^a   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenin; Laminin; Peripheral arterial occlusive disease; Serum

Indexed keywords

ANGIOGENIN; LAMININ;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 0029994790     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.6.508     Document Type: Article

References (18)

1. Timpl R, Rohde H, Risteli L, Ott U, Robey PG, Martin GR. Laminin. Methods Enzymol 1982;82:831-8.
2. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin - a glycoprotein from basement membranes. J Biol Chem 1979;254:9933-7.
3. Hasselbalch H, Junker P. Serum laminin P1 in idiopathic myelofibrosis and related diseases. Leuk Res 1994; 18:623-8.
4. Guseva NG, Anikina NV, Myllyla R, Risteli L, Risteli J, Chochlova JV, et al. Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosis. Ann Rheum Dis 1991;50:481-6.
5. Wenisch C, Myskiw D, Narzt E, Presterl E, Graninger W. Laminin in Graves' Disease. Eur J Clin Invest 1995; 25:425-8.
6. Parise ER, Leite Mor MM, Rosa H. Serum laminin in hepatosplenic human schistosomiasis. Mem Inst Oswaldo Cruz 1992;87(Suppl 4):127 8.
7. Marx JL. Angiogenesis research comes of age. Science 1987; 237:23-4.
8. Ribatti D, Vacca A, Roncali L, Dammacco F. Angiogenesis under normal and pathological conditions. Haematologica 1991;76:311-20.
9. Badet J, Soncin F, N'Guyen T, Barritault D. In vivo and in vitro studies of angiogenin - a potent angiogenic factor. Blood Coagul Fibrinolysis 1990;1:721-4.
10. Shapiro R, Strydom DJ, Olson KA, Vallee BL. Isolation of angiogenin from normal human plasma. Biochemistry 1987;26:5141-6.
11. Skalkidis Y, Katsouyanni K, Petridou E, Sehas M, Trichopoulos D. Risk factors of peripheral arterial occlusive disease: a case-control study in Greece. Int J Epidemiol 1989;18:614-18.
12. Szirmai IG, Kamondi A, Magyar H, Juhasz C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993;24:1811-16.
13. Bini A, Kudryk BJ. Fibrinogen and fibrin in the arterial wall. Thromb Res 1994;75:337-41.
14. Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JH, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 1994;72:250-4.
15. Ernst E. Fibrinogen as a cardiovascular risk factor - interrelationship with infections and inflammation. Eur Heart J 1993;14(Suppl K):82-7.
16. Pilgeram L. Atherogenesis and fibrinogen: historical perspective and current status. Naturwissenschafien 1993; 80:547 55.
17. Risteli J, Draeger KE, Regitz G, Neubauer HP. Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia 1982; 23:266-9.
18. Wenisch C, Graninger W, Viravan C, Looareesuwan S, Parschalk B, Wernsdorfer W. Serum laminin in malaria. J Clin Pathol 1994;47:787-9.